Cross-border biopharma commercialization & growth.

Expanding across the Atlantic requires more than transferring a successful model. InspInno helps companies understand local market dynamics, make informed commercialization decisions, and build the capabilities required for sustainable growth.

Two markets. Two directions. One experienced partner.

The U.S. and Europe have distinct healthcare systems, access requirements and commercial environments. Expansion requires market-specific decisions, not a one-size-fits-all plan.

Statue of Liberty on the left, Eiffel Tower on the right, with U.S. and EU flags, sunset and connecting arcs

U.S. → Europe

Helping U.S. biotech and pharmaceutical companies prioritize European markets, prepare for launch and build sustainable regional growth.

European market entry strategy and prioritization
Commercialization and launch readiness
EU pricing, reimbursement, government affairs and early access programs supported by an experienced specialist European partner
Operating model, organizational design and country strategy
Business development and partnerships

European market strategy

Prioritize EU markets; coordinate country-specific pricing, reimbursement, government affairs and early access support through a specialist European partner.

Launch and operating model

Define launch readiness, partnerships, capability building and local execution.

Eiffel Tower on the left, Statue of Liberty on the right, with EU and U.S. flags, sunset and connecting arcs

Europe → U.S.

Helping European biotech and healthcare companies translate innovation and experience into a viable U.S. commercial strategy.

U.S. market entry and go-to-market strategy
U.S. launch readiness and commercialization
U.S. payer, pricing and access considerations for market-entry planning
Commercial organization and capability planning
Strategic partnerships, portfolio and asset assessment

U.S. commercial strategy

Assess market opportunity, payer dynamics, positioning and commercialization investments.

Go-to-market and partnerships

Plan the launch organization, licensing choices and commercial execution.